Prevalence of potential familial hypercholesteremia (FH) in 54,811 statin-treated patients in clinical practice

Catapano A. L. , Lautsch D., Tokgozoglu L. , Ferrieres J., Horack M., Farnier M., ...Daha Fazla

ATHEROSCLEROSIS, cilt.252, ss.1-8, 2016 (SCI İndekslerine Giren Dergi) identifier identifier identifier


Background and aims: Familial hypercholesterolemia (FH) is a life-threatening disease, characterized by elevated LDL-C levels and a premature, increased risk of coronary heart disease (CHD) that is globally underdiagnosed. The percentage of patients with possible or probable FH in various countries was examined in the Dyslipidemia International Study (DYSIS).